M
MedTrace
MedTrace Pharma innovates medical imaging to help doctors diagnose patients faster and more accurately, with lower costs, while boosting patient comfort
About MedTrace
Developer of medical devices designed to offer novel safety features to revolutionize blood flow imaging in PET. The company's devices automate bedside production and infusion of radioactive water in the PET scanner suite and consist of a remotely operated unit producing the radioactive water to innovate PET diagnostic imaging by transforming blood flow quantification, enabling physicians to get a platform that assists them to focus on heart-study applications, brain and tumor vascularization, and diabetes studies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Kongens Lyngby, Denmark
- Employees
- 43
- Open positions
- None listed
- Dealroom signal
- 78.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Medical Imaging, EIC, Tech for Hospitals and Clinics, Clinical Decision Support, EIC Fund
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES FOther financing | May 2025 | $11M | $44M | BankInvest · Verve Ventures · Swisscanto Invest · ATP | ↗ |
| SERIES COther financing | Sep 2023 | $20M | $80M | Swisscanto Invest · MedTravest · Verve Ventures · ATP | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for MedTrace is 880 monthly website visits, down 26.7% over the last three months. MedTrace's team grew 2.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A6 investors entered at this stage
Syddansk Innovation
EIC Fund
BankInvest
Verve Ventures
Swisscanto Invest
ATP
Series B and later1 investor entered at this stage
- MEMedTravest
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedTrace on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedTrace’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







